![Akiko Iwasaki](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Akiko Iwasaki
Profil
Akiko Iwasaki is the founder of RIGImmune, Inc. (2020) and PanV, Inc. (2023).
Current jobs include Director at Genentech, Inc., Independent Non-Executive Director at Roche Holding AG, Member at Howard Hughes Medical Institute, Inc., Member-Scientific Counselors at The Broad Institute, Inc., and Professor at Yale University School of Medicine.
Former jobs include Advisor at 4BIO Ventures Management Ltd. and Member at The American Association of Immunologists (2018-2025).
Education includes an undergraduate degree from the University of Toronto (1994) and a doctorate from the University of Toronto (1998).
Aktuelle Nachrichten zu Akiko Iwasaki
Aktive Positionen von Akiko Iwasaki
| Unternehmen | Position | Beginn |
|---|---|---|
| ROCHE HOLDING AG | Direktor/Vorstandsmitglied | 01.03.2023 |
Genentech, Inc.
 Genentech, Inc. Operates as a biotechnology company that develops medicines for cancer peoples | Direktor/Vorstandsmitglied | - |
Howard Hughes Medical Institute, Inc.
 Howard Hughes Medical Institute, Inc. Investment Trusts/Mutual FundsMiscellaneous Functions as a foundation or endowment | Corporate Officer/Principal | 01.01.2021 |
The Broad Institute, Inc.
 The Broad Institute, Inc. BiotechnologyHealth Technology Engages in research and development in bio medicals to cure infectious disease, cancer, psychiatric research and cardiovascular diseases | Corporate Officer/Principal | 01.01.2023 |
Ehemalige bekannte Positionen von Akiko Iwasaki
| Unternehmen | Position | Ende |
|---|---|---|
The American Association of Immunologists
 The American Association of Immunologists Miscellaneous Commercial ServicesCommercial Services The American Association of Immunologists is a company based in Bethesda, MD. | Corporate Officer/Principal | 01.01.2025 |
Xanadu Bio Inc.
 Xanadu Bio Inc. Operates as a nanoparticle delivery platform intended to offer delivery of mRNA and nucleic acids | Gründer | - |
RIGImmune, Inc.
 RIGImmune, Inc. Operates biopharmaceutical research company that develops RNA immunotherapies | Gründer | - |
4BIO Ventures Management Ltd.
 4BIO Ventures Management Ltd. 4bio Ventures invest in companies located in the United Kingdom. The firm targets the companies operating in the fields of gene therapy, cell theray, RNA based therapy, targeted therapies and microbiome. They provide financing for early stage capital requirements. | Berater | - |
Ausbildung von Akiko Iwasaki
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 9 |
|---|---|
Genentech, Inc.
Genentech, Inc. Operates as a biotechnology company that develops medicines for cancer peoples | |
Roche Holding AG
 Roche Holding AG Operates as a research-focused healthcare company with combined focus in pharmaceuticals and diagnostics | |
Howard Hughes Medical Institute, Inc.
Howard Hughes Medical Institute, Inc. Investment Trusts/Mutual FundsMiscellaneous Functions as a foundation or endowment | Miscellaneous |
University of Toronto
 University of Toronto Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
The American Association of Immunologists
The American Association of Immunologists Miscellaneous Commercial ServicesCommercial Services The American Association of Immunologists is a company based in Bethesda, MD. | Commercial Services |
The Broad Institute, Inc.
The Broad Institute, Inc. BiotechnologyHealth Technology Engages in research and development in bio medicals to cure infectious disease, cancer, psychiatric research and cardiovascular diseases | Health Technology |
4BIO Ventures Management Ltd.
4BIO Ventures Management Ltd. 4bio Ventures invest in companies located in the United Kingdom. The firm targets the companies operating in the fields of gene therapy, cell theray, RNA based therapy, targeted therapies and microbiome. They provide financing for early stage capital requirements. | |
RIGImmune, Inc.
RIGImmune, Inc. Operates biopharmaceutical research company that develops RNA immunotherapies | |
Xanadu Bio Inc.
Xanadu Bio Inc. Operates as a nanoparticle delivery platform intended to offer delivery of mRNA and nucleic acids |
